Motilal Oswal
  • SENSEX
    NIFTY 50
Motilal Oswal
Market

Top brokerage calls for June 20: Morgan Stanley 'overweight' on Apollo Hospitals, CLSA remains bearish on Asian Paints

Updated : 2019-06-20 08:18:08

The Indian benchmark indices are set to open on a positive note after US Fed left key rates unchanged but signalled possible interest rate cuts later this year. On Wednesday, benchmark indices ended flat on the back of selective buying and selling in equities. Among brokerages, CLSA retained 'sell' call on Asian Paints, while, HSBC is bullish on UPL. Morgan Stanley is 'overweight' on Apollo Hospitals post the deal with HDFC, whereas, Jefferies maintains a 'hold' rating. Here are the top brokerage calls for Thursday:

<strong>CLSA on Asian Paints</strong>: The brokerage retained 'sell' call on the stock with a target at Rs 1,285 per share. Macro factors, tapering growth and volatile crude are key worries, it added.
CLSA on Asian Paints: The brokerage retained 'sell' call on the stock with a target at Rs 1,285 per share. Macro factors, tapering growth and volatile crude are key worries, it added.
<strong>Morgan Stanley on Apollo Hospitals:</strong> The brokerage is 'overweight' on the stock with a target at Rs 1,667 per share. According to the brokerage, the Apollo Munich stake sale is a major liquidity event and should help reduce the leverage.
Morgan Stanley on Apollo Hospitals: The brokerage is 'overweight' on the stock with a target at Rs 1,667 per share. According to the brokerage, the Apollo Munich stake sale is a major liquidity event and should help reduce the leverage.
<strong>Jefferies On HDFC and Apollo Hospitals</strong>: According to the brokerage, the deal will aid Apollo Group in the reduction of pledge shares of promoters. It has a 'hold' rating on Apollo Hospitals with a target at Rs 1,250 per share.
Jefferies On HDFC and Apollo Hospitals: According to the brokerage, the deal will aid Apollo Group in the reduction of pledge shares of promoters. It has a 'hold' rating on Apollo Hospitals with a target at Rs 1,250 per share.
<strong>Nomura on Apollo Hospitals</strong>: The brokerage maintained 'buy' rating on Apollo Hospitals, saying the Apollo Munich transaction is an incremental positive.
Nomura on Apollo Hospitals: The brokerage maintained 'buy' rating on Apollo Hospitals, saying the Apollo Munich transaction is an incremental positive.
<strong>Nomura on Fortis</strong>: The brokerage has a 'buy' call on the stock but has cut its target price to Rs 159 per share from Rs 171 earlier. It expects a gradual recovery following a challenging FY19.
Nomura on Fortis: The brokerage has a 'buy' call on the stock but has cut its target price to Rs 159 per share from Rs 171 earlier. It expects a gradual recovery following a challenging FY19.
<strong>HSBC on UPL</strong>: The brokerage maintained 'buy' rating on UPL and said that the company is at risk due to its global diversified exposure.
HSBC on UPL: The brokerage maintained 'buy' rating on UPL and said that the company is at risk due to its global diversified exposure.
<strong>CLSA on India Strategy</strong>: The brokerage said that the May indicators point to a weak economy.  RBI has taken cognizance of slower growth, however, the fiscal space is limited to carry out any growth enhancement measures, it added.
CLSA on India Strategy: The brokerage said that the May indicators point to a weak economy.  RBI has taken cognizance of slower growth, however, the fiscal space is limited to carry out any growth enhancement measures, it added.
Live TV

Ask Our Experts CNBC TV18